At the news
? NEUTRALIMPACT 2/10 8-K filed Sep 1, 2026 at 06:06 ET
AptarGroup appointed Gael Touya to the Board of Directors, effective September 1, 2026, increasing board size from 10 to 11. Touya, who previously served as President of the Aptar Pharma segment, became President and CEO on the same date, succeeding Stephan B. Tanda who retired. This is a routine governance filing formalizing the CEO's board seat; no additional compensation for board service is provided as Touya is an employee.
- Board increased from 10 to 11 directors
- Gael Touya appointed as director effective September 1, 2026
- Touya became President and CEO on September 1, 2026, succeeding Stephan B. Tanda (retired)
- Touya previously served as President of Aptar Pharma segment
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access